We evaluated its anticancer activities using human and mouse GBM cell lines in vitro and mouse orthograft and transgenic (PEPG - PTENflox/+; EGFRvIII+; p16Flox/− & GFAP Cre +)  in vivo models. Here, GFAP is linked to glioblastoma.